封面
市場調查報告書
商品編碼
1400594

輔酶 Q10 市場規模 -按應用(藥品、膳食補充劑、化妝品)、研究報告、國家展望、價格趨勢、成長前景、競爭產業佔有率和全球預測,2023-2032 年

Coenzyme Q10 Market Size - By Application (Pharmaceuticals, Dietary Supplements, Cosmetics), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Global Forecast, 2023-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

由於該領域的蓬勃發展,全球輔酶 Q10 市場在 2023 年至 2032 年間的CAGR將超過 10.5%。隨著人們對健康和保健的日益關注,研究揭示了輔酶 Q10 對心臟健康、能量產生和抗氧化特性的潛在益處,引起了人們的極大興趣。

例如,2023 年11 月,伊朗研究人員團隊撰寫並發表在《國際生物化學研究》雜誌上的一篇題為“輔酶Q10 在各種神經退化性和精神疾病中的參與”的評論文章指出,輔酶Q10 (CoQ10)(一種內在抗氧化劑)存在於體內和某些食物中,可能有助於治療弗里德賴希共濟失調和其他神經系統疾病等疾病。研究人員提出,CoQ10 的抗氧化和能量調節特性可能會保護神經系統免於退化和衰退。

探勘的激增刺激了需求,迫使各行業創新和增強 CoQ10 配方以實現更廣泛的應用。隨著科學努力揭示其多方面的優勢,市場成長軌跡與現代對改善健康解決方案的追求相一致。

輔酶 Q10 的整體市場佔有率根據應用和地區進行分類。

2023年至2032年,製藥領域的輔酶Q10市場規模將出現顯著的CAGR。製藥業看重輔酶Q10在治療心血管問題、神經系統疾病以及在癌症治療中的潛在應用的作用。憑藉其抗氧化特性並參與細胞能量產生,輔酶 Q10 有望增強藥物配方和補充各種療法。藥品需求的不斷成長反映了人們對 CoQ10 的不斷探索和利用,將其作為推進醫療干預措施以改善健康結果的重要組成部分。

亞太地區輔酶Q10產業將在2023年至2032年呈現出值得稱讚的CAGR。隨著預防保健意識的不斷提高,膳食補充劑和化妝品中輔酶Q10的消費量將激增。這一趨勢是由其抗氧化特性和據稱對心臟健康的益處所推動的。此外,亞太地區的老年人口正在尋求 CoQ10,因為它具有解決與年齡相關的健康問題的潛力。

這種不斷成長的需求反映了該地區對整體健康實踐的傾向,推動了各行業 CoQ10 市場的成長。例如,2021 年 8 月,由總裁田中稔領導、總部位於東京港區的鐘化株式會社宣布,輔酶 Q10 的活性變體可有效緩解短暫疲勞。最近的功能聲明證實了它能夠在暫時壓力下提高睡眠品質、減輕這種壓力並有助於維持口腔濕潤。因此,由總裁 Shoji Nagae 領導、總部位於東京港區的 Kaneka Your Health Care Co., Ltd. 推出了名為“Watashi no ChikaraTM”的新穎產品系列,具有這些功能優勢。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:全球輔酶 Q10 產業洞察

  • 行業細分
  • COVID-19 對世界經濟的影響
  • 產業生態系統分析
    • 供應商矩陣
    • 配銷通路分析
      • 經銷商
      • 供應商
      • 合約起草(名詞
      • 技術提供者
  • 原料分析:Covid-19 對供給的影響
    • Covid-19 對供應的影響
  • 產業格局,2018 - 2032
  • 技術景觀
  • 監管環境
    • 歐洲
  • 定價分析
      • 區域定價:COVID-19 的影響
      • 成本結構分析
  • 產業影響力
    • 成長動力
      • 北美:化妝品需求不斷成長
      • 歐洲:糖尿病和心血管疾病的盛行率不斷上升
      • 亞太地區:醫藥市場擴張導致需求上升
    • 產業陷阱與挑戰
      • 最低劑量要求
  • 創新與永續發展
  • 2022 年成長潛力分析
    • 新興商業模式
      • 新產品發布
      • 合作
  • 波特的分析
  • 2022 年競爭格局
    • 2022 年公司市佔率分析
    • 頂級球員概覽
    • 戰略儀表板
  • PESTEL分析
  • COVID-19 對輔酶 Q10 需求的影響(按應用分類)
    • 膳食補充劑
    • 藥品
    • 化妝品
    • 其他

第 4 章:全球輔酶 Q 10 市場:按應用

  • 主要應用趨勢
  • 藥品
  • 膳食補充劑
  • 化妝品
  • 其他

第 5 章:全球輔酶 Q 10 市場:按地區

  • 主要區域趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 波蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
  • 拉丁美洲 (LATAM)
    • 巴西
    • 墨西哥
  • 中東和非洲 (MEA)

第 6 章:公司簡介

  • Kaneka Corporation
  • DSM
  • SourceOne Global Partners, LLC
  • Healthy Origins
  • Vitamin Shoppe, Inc.
  • NBTY, Inc.
  • Pharmavite LLC
  • QUTEN Research Institute LLC
  • Tishcon Corp.
  • Country Life, LLC
  • Natural Organics
  • Jarrow Formulas
  • NOW Foods
  • Pharma Nord, Inc.
  • Doctor's Best
  • Xiamen Kingdomway Group
  • GNC Holdings, Inc.
  • Nordic Naturals, Inc.

第 7 章:潛在客戶

  • 默克公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 雅培實驗室
    • 商業概覽
    • 財務數據
    • 產品格局
  • 太陽藥業有限公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 輝瑞公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 賽諾菲
    • 商業概覽
    • 財務數據
    • 產品格局
  • 百時美施貴寶
    • 商業概覽
    • 財務數據
    • 產品格局
  • 諾華公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 強生公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 葛蘭素史克
    • 商業概覽
    • 財務數據
    • 產品格局
  • 聯合利華
    • 商業概覽
    • 財務數據
    • 產品格局
  • 雅芳產品公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 拜爾斯多夫
    • 商業概覽
    • 財務數據
    • 產品格局
  • 漢高股份公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 歐瑞蓮控股公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 雅詩蘭黛公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 伊夫·羅徹
    • 商業概覽
    • 財務數據
    • 產品格局
  • 資生堂有限公司
    • 商業概覽
    • 財務數據
    • 產品格局
  • 矢車菊營養
    • 商業概覽
    • 財務數據
    • 產品格局
  • 巴林的
    • 商業概覽
    • 財務數據
    • 產品格局
  • 自然因素
    • 商業概覽
    • 財務數據
    • 產品格局
  • 延長壽命
    • 商業概覽
    • 財務數據
    • 產品格局
Product Code: 741

Global Coenzyme Q10 Market will witness over 10.5% CAGR between 2023 and 2032 due to burgeoning research and development in the field. With increased focus on health and wellness, studies revealing CoQ10's potential benefits in heart health, energy production, and antioxidant properties have sparked immense interest.

For instance, in November 2023, A recent review article titled "Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases," penned by a team of Iranian researchers and published in Biochemistry Research International, suggested that Coenzyme Q10 (CoQ10), an intrinsic antioxidant present in the body and certain foods, could potentially aid in treating conditions like Friedreich's ataxia and other neurological ailments. The researchers propose that CoQ10's antioxidative and energy-regulating properties might safeguard the neurological system from degeneration and decline.

This surge in exploration fuels demand, compelling industries to innovate and enhance CoQ10 formulations for wider applications. As scientific endeavors unravel its multifaceted advantages, the market growth trajectory aligns with the quest for improved health solutions in modern times.

The overall Coenzyme Q10 Market share is classified based on application and region.

Coenzyme Q10 market size from the pharmaceuticals segment will register a noteworthy CAGR from 2023 to 2032. Pharmaceutical industries value CoQ10 for its role in treating cardiovascular issues, neurological disorders, and potential applications in cancer treatment. With its antioxidant properties and involvement in cellular energy production, CoQ10 holds promise in enhancing drug formulations and supplementing various therapies. This escalating demand within pharmaceuticals reflects the continuous exploration and utilization of CoQ10 as a vital component in advancing medical interventions for improved health outcomes.

Asia Pacific coenzyme Q10 industry will showcase a commendable CAGR from 2023 to 2032. With rising awareness of preventive healthcare, there is a surge in CoQ10 consumption in dietary supplements and cosmetics. This trend is propelled by its antioxidant properties and purported benefits in heart health. Moreover, Asia Pacific's aging population seeks CoQ10 for its potential in addressing age-related health concerns.

This increasing demand reflects the region's inclination toward holistic health practices, driving the CoQ10 market growth across diverse industries. For instance, in August 2021, Kaneka Corporation, led by President Minoru Tanaka and headquartered in Minato-ku, Tokyo, declared that the active variant of Coenzyme Q10 demonstrates efficacy in alleviating transient fatigue. Recent functional claims endorse its ability to enhance sleep quality amidst temporary stress, reduce such stress, and aid in sustaining oral moisture. Consequently, Kaneka Your Health Care Co., Ltd., helmed by President Shoji Nagae and also based in Minato-ku, Tokyo, introduced a novel product line named "Watashi no ChikaraTM," featuring these functional benefits.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Global coenzyme Q10 industry 360 degree synopsis, 2023 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Application trend

Chapter 3 Global coenzyme Q10 Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Impact of COVID-19 on world economy
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Vendor matrix
    • 3.3.2 Distribution channel analysis
      • 3.3.2.1 Distributor
      • 3.3.2.2 Suppliers
      • 3.3.2.3 Contract Manufacturing
      • 3.3.2.4 Technology providers
  • 3.4 Raw material analysis: Covid-19 impact on supply
    • 3.4.1 Covid-19 impact on supply
  • 3.5 Industry landscape, 2018 - 2032
  • 3.6 Technology landscape
  • 3.7 Regulatory landscape
    • 3.7.1 Europe
  • 3.8 Pricing analysis
      • 3.8.1.1 Regional pricing: COVID-19 impact
      • 3.8.1.2 Cost structure analysis
  • 3.9 Industry impact forces
    • 3.9.1 Growth drivers
      • 3.9.1.1 North America: Growing demand for cosmetics product
      • 3.9.1.2 Europe: Increasing prevalence of diabetes and cardiovascular diseases
      • 3.9.1.3 Asia Pacific: Pharmaceutical market expansion leading to rising demand
    • 3.9.2 Industry pitfalls & challenges
      • 3.9.2.1 Minimum dosage requirement
  • 3.10 Innovation & sustainability
  • 3.11 Growth potential analysis, 2022
    • 3.11.1 Emerging business model
      • 3.11.1.1 New Product Launch
      • 3.11.1.2 Collaboration
  • 3.12 Porter's analysis
    • 3.12.1 Bargaining power of suppliers
    • 3.12.2 Bargaining power of buyers
    • 3.12.3 Threat of new entrants
    • 3.12.4 Threat of substitutes
  • 3.13 Competitive landscape, 2022
    • 3.13.1 Company market share analysis, 2022
    • 3.13.2 Top players overview
    • 3.13.3 Strategy dashboard
  • 3.14 PESTEL analysis
  • 3.15 COVID-19 impact on Coenzyme Q10 demand, by application
    • 3.15.1 Dietary Supplements
    • 3.15.2 Pharmaceuticals
    • 3.15.3 Cosmetics
    • 3.15.4 Others

Chapter 4 Global Coenzyme Q 10 Market, By Application

  • 4.1 Key application trends
  • 4.2 Pharmaceuticals
    • 4.2.1 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
    • 4.2.2 Global coenzyme Q10 market from pharmaceutical application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.3 Dietary Supplements
    • 4.3.1 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
    • 4.3.2 Global coenzyme Q10 market from dietary supplements application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.4 Cosmetics
    • 4.4.1 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
    • 4.4.2 Global coenzyme Q10 market from cosmetics application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.5 Others
    • 4.5.1 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
    • 4.5.2 Global coenzyme Q10 market from other application, by region, 2018 - 2032, (Tons) (USD Million)

Chapter 5 Global Coenzyme Q 10 Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.2.2 North America coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.3.2 U.S. coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.4.2 Canada coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.3.2 Europe coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.3.2 Germany coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.4.2 UK coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.5 France
      • 5.3.5.1 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.5.2 France coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.6 Italy
      • 5.3.6.1 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.6.2 Italy coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.7 Russia
      • 5.3.7.1 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.7.2 Russia coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.8 Poland
      • 5.3.8.1 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.8.2 Poland coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.4.2 Asia Pacific coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.3.2 China coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.4.2 India coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.5 Japan
      • 5.4.5.1 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.5.2 Japan coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.5 Latin America (LATAM)
    • 5.5.1 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.5.2 LATAM coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.3.2 Brazil coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.4.2 Mexico coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.6 Middle East & Africa (MEA)
    • 5.6.1 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.6.2 MEA coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)

Chapter 6 Company Profiles

  • 6.1 Kaneka Corporation
    • 6.1.1 Business Overview
    • 6.1.2 Financial Data
    • 6.1.3 Product Landscape
    • 6.1.4 SWOT Analysis
  • 6.2 DSM
    • 6.2.1 Business Overview
    • 6.2.2 Financial Data
    • 6.2.3 Product Landscape
    • 6.2.4 SWOT Analysis
  • 6.3 SourceOne Global Partners, LLC
    • 6.3.1 Business Overview
    • 6.3.2 Financial Data
    • 6.3.3 Product Landscape
    • 6.3.4 SWOT Analysis
  • 6.4 Healthy Origins
    • 6.4.1 Business Overview
    • 6.4.2 Financial Data
    • 6.4.3 Product Landscape
    • 6.4.4 SWOT Analysis
  • 6.5 Vitamin Shoppe, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Data
    • 6.5.3 Product Landscape
    • 6.5.4 SWOT Analysis
  • 6.6 NBTY, Inc.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Data
    • 6.6.3 Product Landscape
    • 6.6.4 SWOT Analysis
  • 6.7 Pharmavite LLC
    • 6.7.1 Business Overview
    • 6.7.2 Financial Data
    • 6.7.3 Product Landscape
    • 6.7.4 SWOT Analysis
  • 6.8 QUTEN Research Institute LLC
    • 6.8.1 Business Overview
    • 6.8.2 Financial Data
    • 6.8.3 Product Landscape
    • 6.8.4 SWOT Analysis
  • 6.9 Tishcon Corp.
    • 6.9.1 Business Overview
    • 6.9.2 Financial Data
    • 6.9.3 Product Landscape
    • 6.9.4 SWOT Analysis
  • 6.10 Country Life, LLC
    • 6.10.1 Business Overview
    • 6.10.2 Financial Data
    • 6.10.3 Product Landscape
    • 6.10.4 SWOT Analysis
  • 6.11 Natural Organics
    • 6.11.1 Business Overview
    • 6.11.2 Financial Data
    • 6.11.3 Product Landscape
    • 6.11.4 SWOT Analysis
    • 6.11.5 Strategic Outlook
  • 6.12 Jarrow Formulas
    • 6.12.1 Business Overview
    • 6.12.2 Financial Data
    • 6.12.3 Product Landscape
    • 6.12.4 SWOT Analysis
  • 6.13 NOW Foods
    • 6.13.1 Business Overview
    • 6.13.2 Financial Data
    • 6.13.3 Product Landscape
    • 6.13.4 SWOT Analysis
  • 6.14 Pharma Nord, Inc.
    • 6.14.1 Business Overview
    • 6.14.2 Financial Data
    • 6.14.3 Product Landscape
    • 6.14.4 SWOT Analysis
  • 6.15 Doctor's Best
    • 6.15.1 Business Overview
    • 6.15.2 Financial Data
    • 6.15.3 Product Landscape
    • 6.15.4 SWOT Analysis
    • 6.15.5 Strategic Outlook
  • 6.16 Xiamen Kingdomway Group
    • 6.16.1 Business Overview
    • 6.16.2 Financial Data
    • 6.16.3 Product Landscape
    • 6.16.4 SWOT Analysis
  • 6.17 GNC Holdings, Inc.
    • 6.17.1 Business Overview
    • 6.17.2 Financial Data
    • 6.17.3 Product Landscape
    • 6.17.4 SWOT Analysis
  • 6.18 Nordic Naturals, Inc.
    • 6.18.1 Business Overview
    • 6.18.2 Financial Data
    • 6.18.3 Product Landscape
    • 6.18.4 SWOT Analysis

Chapter 7 Potential Customers

  • 7.1 Merck & Co.
    • 7.1.1 Business Overview
    • 7.1.2 Financial Data
    • 7.1.3 Product Landscape
  • 7.2 Abbott Laboratories
    • 7.2.1 Business Overview
    • 7.2.2 Financial Data
    • 7.2.3 Product Landscape
  • 7.3 Sun Pharmaceutical Industries Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Data
    • 7.3.3 Product Landscape
  • 7.4 Pfizer
    • 7.4.1 Business Overview
    • 7.4.2 Financial Data
    • 7.4.3 Product Landscape
  • 7.5 Sanofi
    • 7.5.1 Business Overview
    • 7.5.2 Financial Data
    • 7.5.3 Product Landscape
  • 7.6 Bristol Myers Squibb
    • 7.6.1 Business Overview
    • 7.6.2 Financial Data
    • 7.6.3 Product Landscape
  • 7.7 Novartis
    • 7.7.1 Business Overview
    • 7.7.2 Financial Data
    • 7.7.3 Product Landscape
  • 7.8 Johnson & Johnson
    • 7.8.1 Business Overview
    • 7.8.2 Financial Data
    • 7.8.3 Product Landscape
  • 7.9 GlaxoSmithKline
    • 7.9.1 Business Overview
    • 7.9.2 Financial Data
    • 7.9.3 Product Landscape
  • 7.10 Unilever
    • 7.10.1 Business Overview
    • 7.10.2 Financial Data
    • 7.10.3 Product Landscape
  • 7.11 Avon Products, Inc
    • 7.11.1 Business Overview
    • 7.11.2 Financial Data
    • 7.11.3 Product Landscape
  • 7.12 Beiersdorf
    • 7.12.1 Business Overview
    • 7.12.2 Financial Data
    • 7.12.3 Product Landscape
  • 7.13 Henkel AG & Co., KGaA
    • 7.13.1 Business Overview
    • 7.13.2 Financial Data
    • 7.13.3 Product Landscape
  • 7.14 Oriflame Holding AG
    • 7.14.1 Business Overview
    • 7.14.2 Financial Data
    • 7.14.3 Product Landscape
  • 7.15 The Estee Lauder Companies Inc.
    • 7.15.1 Business Overview
    • 7.15.2 Financial Data
    • 7.15.3 Product Landscape
  • 7.16 Yves Rocher
    • 7.16.1 Business Overview
    • 7.16.2 Financial Data
    • 7.16.3 Product Landscape
  • 7.17 Shiseido Company, Limited
    • 7.17.1 Business Overview
    • 7.17.2 Financial Data
    • 7.17.3 Product Landscape
  • 7.18 Bluebonnet Nutrition
    • 7.18.1 Business Overview
    • 7.18.2 Financial Data
    • 7.18.3 Product Landscape
  • 7.19 Barlean's
    • 7.19.1 Business Overview
    • 7.19.2 Financial Data
    • 7.19.3 Product Landscape
  • 7.20 Natural Factors
    • 7.20.1 Business Overview
    • 7.20.2 Financial Data
    • 7.20.3 Product Landscape
  • 7.21 LifeExtension
    • 7.21.1 Business Overview
    • 7.21.2 Financial Data
    • 7.21.3 Product Landscape

Data Tables

  • TABLE 1 Global coenzyme Q10 industry 3600 synopsis, 2023 - 2032
  • TABLE 2 Global coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 3 Global coenzyme Q10 market volume, by region, 2018 - 2032, (Tons)
  • TABLE 4 Global coenzyme Q10 market revenue, by region, 2018 - 2032, (USD Million)
  • TABLE 5 Global coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 6 Global coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 7 Vendor matrix
  • TABLE 8 CoQ10 distribution channel analysis
  • TABLE 9 Industry impact forces
  • TABLE 10 Top players overview
  • TABLE 11 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 12 Global coenzyme Q10 market volume from pharmaceutical application, by region, 2018 - 2032, (Tons)
  • TABLE 13 Global coenzyme Q10 market revenue from pharmaceutical application, by region, 2018 - 2032, (USD Million)
  • TABLE 14 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 15 Global coenzyme Q10 market volume from dietary supplements application, by region, 2018 - 2032, (Tons)
  • TABLE 16 Global coenzyme Q10 market revenue from dietary supplements application, by region, 2018 - 2032, (USD Million)
  • TABLE 17 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 18 Global coenzyme Q10 market volume from cosmetics application, by region, 2018 - 2032, (Tons)
  • TABLE 19 Global coenzyme Q10 market revenue from cosmetics application, by region, 2018 - 2032, (USD Million)
  • TABLE 20 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 21 Global coenzyme Q10 market volume from other application, by region, 2018 - 2032, (Tons)
  • TABLE 22 Global coenzyme Q10 market revenue from other application, by region, 2018 - 2032, (USD Million)
  • TABLE 23 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 24 North America coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 25 North America coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 26 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 27 U.S. coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 28 U.S. coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 29 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 30 Canada coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 31 Canada coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 32 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 33 Europe coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 34 Europe coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 35 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 36 Germany coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 37 Germany coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 38 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 39 UK coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 40 UK coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 41 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 42 France coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 43 France coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 44 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 45 Italy coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 46 Italy coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 47 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 48 Russia coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 49 Russia coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 50 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 51 Poland coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 52 Poland coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 53 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 54 Asia Pacific coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 55 Asia Pacific coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 56 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 57 China coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 58 China coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 59 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 60 India coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 61 India coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 62 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 63 Japan coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 64 Japan coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 65 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 66 LATAM coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 67 LATAM coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 68 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 69 Brazil coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 70 Brazil coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 71 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 72 Mexico coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 73 Mexico coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 74 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 75 MEA coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 76 MEA coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 Global heart conditions & statistics, 2019, (% share)
  • FIG. 2 Global cosmetic market share by category, 2019, (% share)
  • FIG. 3 Europe cosmetic market by country, 2019, (USD billion)
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry ecosystem analysis
  • FIG. 6 Global CoQ10 market estimates and forecast, 2018 - 2032 (Tons) (USD Million)
  • FIG. 7 Coenzyme Q10 technology landscape
  • FIG. 8 Lactobacilli price trends (USD/kilo)
  • FIG. 9 North America cosmetics market, 2018, (USD Million)
  • FIG. 10 Europe diabetes data, 2019, (% share)
  • FIG. 11 Europe attributable factors risk factors for CVD, 2020, (% share)
  • FIG. 12 Asia Pacific pharmaceutical market, 2017-2031, (USD Billion)
  • FIG. 13 Growth potential analysis, 2022
  • FIG. 14 Porter's analysis
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 PESTEL analysis
  • FIG. 17 SWOT Analysis, Kaneka Corporation
  • FIG. 18 SWOT Analysis, DSM
  • FIG. 19 SWOT Analysis, SourceOne Global Partners
  • FIG. 20 SWOT Analysis, Healthy Origins
  • FIG. 21 SWOT Analysis, Vitamin Shoppe, Inc
  • FIG. 22 SWOT Analysis, Nature's Bounty Co
  • FIG. 23 SWOT Analysis, Pharmavite LLC
  • FIG. 24 SWOT Analysis, Quten Research Institute
  • FIG. 25 SWOT Analysis, Tishcon Corp
  • FIG. 26 SWOT Analysis, Country Life, LLC
  • FIG. 27 SWOT Analysis, Natural Organics
  • FIG. 28 SWOT Analysis, Jarrow Formulas
  • FIG. 29 SWOT Analysis, NOW Foods
  • FIG. 30 SWOT Analysis, Pharma Nord
  • FIG. 31 SWOT Analysis, Doctor's Best, Inc
  • FIG. 32 SWOT Analysis, Xiamen Kingdomway Group
  • FIG. 33 SWOT Analysis, GNC Holdings, Inc
  • FIG. 34 SWOT Analysis, Nordic Naturals, Inc